Attenuation of N-methyl-D-aspartate-mediated cytoplasmic vacuolization in primary rat hippocampal neurons by mood stabilizers

Neuroscience

Volumn 117, Issue 4, 2003, Pages 949-955

  Bown, C D ^a   Wang, J F ^a   Young, L T ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Carbamazepine; Lithium; Neuroprotection; Transmission electron microscopy; Vacuolization; Valproate

Indexed keywords

CARBAMAZEPINE; LITHIUM; N METHYL DEXTRO ASPARTIC ACID; VALPROIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL ULTRASTRUCTURE; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; FETUS; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0037430761     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00743-1     Document Type: Article

References (59)

1. Adams J.M., Cory S. The Bcl-2 protein family arbiters of cell survival . Science. 281:1998;1322-1326.
2. Ambrosio A.F., Silva A.P., Malva J.O., Soares-da-Silva P., Carvalho A.P., Carvalho C.M. Carbamazepine inhibits L-type Ca2+ channels in cultured rat hippocampal neurons stimulated with glutamate receptor agonists. Neuropharmacology. 38:1999;1349-1359.
3. Banker G.A., Cowan W.M. Rat hippocampal neurons in dispersed cell culture. Brain Res. 126:1977;1349-1359.
4. Bartlett W.P., Banker G.A. An electron microscopic study of the development of axons and dendrites by hippocampal neurons in culture. I. Cells which develop without intercellular contacts. J Neurosci. 4:1984;1944-1953.
5. Benes F.M., Vincent S.L., Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry. 50:2001;395-406.
6. Bown C.D., Wang J., Young L.T. Increased expression of endoplasmic reticulum stress proteins following chronic valproate treatment of rat C6 glioma cells. Neuropharmacology. 39:2000;2162-2169.
7. Bown C.D., Wang J.F., Azzam J.E., Sun X.J., Young L.T. Protective effect of the mood stabilizers lithium and valproate. Soc Neurosci Abstr. 27:2001;872.9.
8. Brewer G.J. Regeneration and proliferation of embryonic and adult rat hippocampal neurons in culture. Exp Neurol. 159:1999;237-247.
9. Brewer G.J., Torricelli J.R., Evege E.K., Price P.J. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res. 35:1993;567-576.
10. Bruckheimer E.M., Cho S.H., Sarkiss M., Herrmann J., McDonnell T.J. The Bcl-2 gene family and apoptosis. Adv Biochem Eng Biotechnol. 62:1998;75-105.
11. Brustovetsky N., Dubinsky J.M. Dual responses of CNS mitochondria to elevated calcium. J Neurosci. 20:2000;103-113.
12. Cameron G.R. Pathology of the cell. 1952;Oliver & Boyd, London.
13. Chen B., Wang J.F., Hill B.C., Young L.T. Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-Fos. Brain Res Mol Brain Res. 70:1999;45-53.
14. Chen B., Wang J.F., Young L.T. Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus. Biol Psychiatry. 48:2000;658-664.
15. Chen B., Wang J.F., Young L.T. Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus. Biol Psychiatry. 48:2000;658-664.
16. Chen G., Huang L.D., Jiang Y.M., Manji H.K. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J Neurochem. 72:1999;1327-1330.
17. Chen G., Zeng W.Z., Yuan P.X., et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem. 72:1999;879-882.
18. Chen R.W., Chuang D.M. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem. 274:1999;6039-6042.
19. Dixon J.F., Hokin L.E. Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proc Natl Acad Sci USA. 95:1998;8363-8368.
20. Dowlatshahi D., MacQueen G., Wang J.F., Chen B., Young L.T. Increased hippocampal supragranular Timm staining in subjects with bipolar disorder. Neuroreport. 11:2000;3775-3778.
21. Eastwood S.L., Harrison P.J. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression a study of complexin mRNAs . Mol Psychiatry. 5:2000;425-432.
22. Fatemi S.H., Earle J.A., McMenomy T. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry. 5:2000;654-663. 571.
23. Fatemi S.H., Earle J.A., Stary J.M., Lee S., Sedgewick J. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Neuroreport. 12:2001;3257-3262.
24. Fawcett D.M. Bloom and Fawcett, a textbook of histology. 1994;Chapman & Hall, New York.
25. Freeman J.K., Goldberg M.P. Confocal microscopic visualization of MK-801-induced cytoplasmic vacuoles in vitro. Psychopharmacol Bull. 30:1994;541-547.
26. Goldberg M.P., Bateman M.C. Taxol attenuates glutamate receptor-mediated neurite swelling in vitro. Soc Neurosci Abstr. 19:1993;26.
27. Hashimoto R., Hough C., Nakazawa T., Yamamoto T., Chuang D.M. Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons involvement of NMDA receptor inhibition possibly by decreasing N2RB tyrosine phosphorylation . J Neurochem. 80:2002;589-597.
28. Hassel B., Iversen E.G., Gjerstad L., Tauboll E. Up-regulation of hippocampal glutamate transport during chronic treatment with sodium valproate. J Neurochem. 77:2001;1285-1292.
29. Henics T., Koszegi T., Szucs G., Kellermayer M.S. Jr., Kellermayer M. Transient cytoplasmic vacuolization in cultured normal and neoplastic cells treated with low molecular weight human serum ultrafiltrate is out inside? Physiol Chem Phys Med NMR. 25:1993;227-236.
30. Henics T., Wheatley D.N. Vacuolar cytoplasmic phase separation in cultured mammalian cells involves the microfilament network and reduces motional properties of intracellular water. Int J Exp Pathol. 78:1997;343-354.
31. Henics T., Wheatley D.N. Cytoplasmic vacuolation, adaptation and cell death a view on new perspectives and features . Biol Cell. 91:1999;485-498.
32. Hough C.J., Irwin R.P., Gao X.M., Rogawski M.A., Chuang D.M. Carbamazepine inhibition of N-methyl-D-aspartate-evoked calcium influx in rat cerebellar granule cells. J Pharmacol Exp Ther. 276:1996;143-149.
33. 2+-dependent collapse of mitochondrial membrane potential and ultrastructural alterations of mitochondria. FEBS Lett. 392:1996;143-147.
34. Law A.J., Deakin J.F. Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. Neuroreport. 12:2001;2971-2974.
35. Lenox R.H., Watson D.G., Patel J., Ellis J. Chronic lithium administration alters a prominent PKC substrate in rat hippocampus. Brain Res. 570:1992;333-340.
36. Liu H., Bowes R.C. III, van de Water B., Sillence C., Nagelkerke J.F., Stevens J.L. Endoplasmic reticulum chaperones GRP78 and calreticulin prevent oxidative stress, Ca2+ disturbances, and cell death in renal epithelial cells. J Biol Chem. 272:1997;21751-21759.
37. 2+ increases and cell death. J Biol Chem. 273:1998;12858-12862.
38. Manji H.K., Moore G.J., Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers implications for the pathophysiology and treatment of manic-depressive illness . Biol Psychiatry. 48:2000;740-754.
39. Manji H.K., Moore G.J., Chen G. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo a role for neurotrophic and neuroprotective effects in manic depressive illness . J Clin Psychiatry. 61:(Suppl 9):2000;82-96.
40. Manji H.K., Moore G.J., Chen G. Bipolar disorder leads from the molecular and cellular mechanisms of action of mood stabilizers . Br J Psychiatry Suppl. 41:2001;s107-s119.
41. Meldrum B.S. Cell damage in epilepsy and the role of calcium in cytotoxicity. Adv Neurol. 44:1986;849-855.
42. 2+ influx. J Biol Chem. 271:1996;9332-9339.
43. Mora A., Gonzalez-Polo R.A., Fuentes J.M., et al. Different mechanisms of protection against apoptosis by valproate and Li+ Dentate granule neuron apoptosis and glia activation in murine hippocampus induced by trimethyltin exposure. Brain Res. 266:1999;886-891.
44. Mosmann T. Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays . J Immunol Methods. 65:1983;55-63.
45. Nigam S.K., Goldberg A.L., Ho S., Rohde M.F., Bush K.T., Sherman M.Y. A set of endoplasmic reticulum proteins possessing properties of molecular chaperones includes Ca(2+)-binding proteins and members of the thioredoxin superfamily. J Biol Chem. 269:1994;1744-1749.
46. Noga J.T., Vladar K., Torrey E.F. A volumetric magnetic resonance imaging study of monozygotic twins discordant for bipolar disorder. Psychiatry Res. 106:2001;25-34.
47. Nonaka S., Hough C.J., Chuang D.M. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci USA. 95:1998;2642-2647.
48. Olney J.W., Labruyere J., Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science. 244:1989;1360-1362.
49. Olney J.W., Labruyere J., Wang G., Wozniak D.F., Price M.T., Sesma M.A. NMDA antagonist neurotoxicity mechanism and prevention . Science. 254:1991;1515-1518.
50. Phillips M., Wang C., Johnson K.M. Pharmacological characterization of locomotor sensitization induced by chronic phencyclidine administration. J Pharmacol Exp Ther. 296:2001;905-913.
51. Pollanen M.S., Quinn B.A., Wollenberg G.K., Hayes M.A. Reversible mitochondrial swelling in cultured rat hepatocytes exposed to 1,2-dimethylhydrazine. Exp Mol Pathol. 52:1990;170-178.
52. Puka-Sundvall M., Hallin U., Zhu C., et al. NMDA blockade attenuates caspase-3 activation and DNA fragmentation after neonatal hypoxia-ischemia. Neuroreport. 11:2000;2833-2836.
53. Strakowski S.M., DelBello M.P., Sax K.W., et al. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry. 56:1999;254-260.
54. van deWater B., Wang Y., Asmellash S., et al. Distinct endoplasmic reticulum signaling pathways regulate apoptotic and necrotic cell death following iodoacetamide treatment. Chem Res Toxicol. 12:1999;943-951.
55. Vawter M.P., Howard A.L., Hyde T.M., Kleinman J.E., Freed W.J. Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia. Mol Psychiatry. 4:1999;467-475.
56. Wang G.J., Thayer S.A. Sequestration of glutamate-induced Ca2+ loads by mitochondria in cultured rat hippocampal neurons. J Neurophysiol. 7:1996;1611-1621.
57. Wang J.F., Bown C., Young L.T. Differential display PCR reveals novel targets for the mood-stabilizing drug valproate including the molecular chaperone GRP78. Mol Pharmacol. 55:1999;521-527.
58. Watson D.G., Watterson J.M., Lenox R.H. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells a property of protein kinase C-mediated mood stabilizers . J Pharmacol Exp Ther. 285:1998;307-316.
59. Yu Z., Luo H., Fu W., Mattson M.P. The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis suppression of oxidative stress and stabilization of calcium homeostasis . Exp Neurol. 155:1999;302-314.